Dalia Haydar, Pharm.D., Ph.D., is an Assistant Professor of Pediatrics at the George Washington University School of Medicine and Health Sciences and a leading Research Faculty member at the Center for Cancer and Immunology Research at Children’s National Hospital. Renowned for her pioneering work in CAR T cell immunotherapy for pediatric brain tumors, Dr. Haydar is dedicated to overcoming the challenges posed by host factors that limit responses to adoptive immunotherapies. Through groundbreaking mechanistic investigations and the application of advanced technologies, she is driving the development of next-generation cellular immunotherapies, poised to significantly enhance outcomes for children battling brain tumors.
